1. Home
  2. RFL vs IOBT Comparison

RFL vs IOBT Comparison

Compare RFL & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.27

Market Cap

54.4M

Sector

Finance

ML Signal

HOLD

Logo IO Biotech Inc.

IOBT

IO Biotech Inc.

HOLD

Current Price

$0.64

Market Cap

57.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RFL
IOBT
Founded
2017
2014
Country
United States
Denmark
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.4M
57.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RFL
IOBT
Price
$1.27
$0.64
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$3.50
AVG Volume (30 Days)
203.9K
713.7K
Earning Date
12-11-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,029,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
47.63
N/A
52 Week Low
$1.12
$0.32
52 Week High
$3.19
$2.79

Technical Indicators

Market Signals
Indicator
RFL
IOBT
Relative Strength Index (RSI) 53.74 44.90
Support Level $1.12 $0.55
Resistance Level $1.28 $0.70
Average True Range (ATR) 0.09 0.07
MACD 0.01 -0.00
Stochastic Oscillator 73.91 45.76

Price Performance

Historical Comparison
RFL
IOBT

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: